Challenges and opportunities in stewardship among solid organ transplant recipients with Candida auris bloodstream infections

被引:7
|
作者
Vu, Christine A. [1 ]
Jimenez, Adriana [2 ,3 ]
Anjan, Shweta [4 ,5 ]
Abbo, Lilian M. [2 ,4 ,5 ]
机构
[1] Jackson Mem Hosp, Dept Pharm, 1611 NW 12th Ave, Miami, FL 33133 USA
[2] Jackson Hlth Syst, Dept Infect Prevent & Control, Miami, FL USA
[3] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Epidemiol, Miami, FL 33199 USA
[4] Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL 33136 USA
[5] Jackson Hlth Syst, Miami Transplant Inst, Miami, FL USA
关键词
antimicrobial stewardship; candida auris; infection prevention; solid organ transplant; RESISTANT; EMERGENCE; DIAGNOSIS;
D O I
10.1111/tid.13919
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Candida auris is an emerging nosocomial pathogen worldwide. However, there has been little published on the management of C. auris in solid organ transplant recipients. Methods A single-center, retrospective cohort study was conducted to evaluate C. auris bloodstream infections in solid organ transplant recipients between January 2020 and December 2021. Patient-related and outcomes data were extracted from electronic medical records. Results Of the 42 patients identified with C. auris bloodstream infections, five were in solid organ transplant recipients (1 heart, 3 liver, and 1 combined liver-kidney). The median time to fungemia from hospital admission was 43 days, and the median time to fungemia from transplant was 18 days. All patients received micafungin as initial treatment, at a median of 6 hours from pathogen detection. Four patients achieved blood clearance, two patients had persistent fungemia, and two patients developed secondary complications from hematogenous spread. One patient died, resulting in a mortality rate of 20%. Conclusions Solid organ transplant recipients are at high risk for developing C. auris bloodstream infections. In order to prevent graft loss and mortality, best practices for the management of C.auris should include rapid screening, diagnosis, and treatment. While echinocandins are considered first-line, antifungal selection should be based on susceptibilities and site of infection. Data to support routine use of combination therapy are lacking, however there may be a role for refractory cases. Prevention efforts against C. auris infection are especially important given the lack of effective decolonization strategies. For transplant recipients, hospitals should seek opportunities to restore patients' gut microbiome by curtailing unnecessary hospital procedures and inappropriate antimicrobial use. Further research and national guidelines are needed to better direct stewardship in this field.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Parasitic Infections in Solid Organ Transplant Recipients
    Kotton, C. N.
    Lattes, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : S234 - S251
  • [32] Parasitic Infections in Solid Organ Transplant Recipients
    Coster, Laura O'Bryan
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2013, 27 (02) : 395 - +
  • [33] Bloodstream infections among intestinal and multivisceral transplant recipients
    Spence, Amanda B.
    Novick, Elizabeth
    Natarajan, Madhuri
    Burkhart, Natalie
    Girlanda, Raffaele
    Timpone, Joseph
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2021,
  • [34] Oral Candida colonization in solid organ transplant recipients
    Dongari-Bagtzoglou, A.
    Ioannidou, E.
    Dwivedi, P.
    Burleson, J.
    Hull, D.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 : S18 - S19
  • [35] White paper on antimicrobial stewardship in solid organ transplant recipients
    So, Miranda
    Hand, Jonathan
    Forrest, Graeme
    Pouch, Stephanie M.
    Te, Helen
    Ardura, Monica, I
    Bartash, Rachel M.
    Dadhania, Darshana M.
    Edelman, Jeffrey
    Ince, Dilek
    Jorgenson, Margaret R.
    Kabbani, Sarah
    Lease, Erika D.
    Levine, Deborah
    Ohler, Linda
    Patel, Gopi
    Pisano, Jennifer
    Spinner, Michael L.
    Abbo, Lilian
    Verna, Elizabeth C.
    Husain, Shahid
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (01) : 96 - 112
  • [36] Cytomegalovirus disease in solid organ transplant recipients: advances lead to new challenges and opportunities
    Eid, Albert J.
    Razonable, Raymund R.
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2007, 12 (06) : 610 - 617
  • [37] Molecular Epidemiology of Extended-Spectrum Cephalosporin-Resistant Enterobacterales Bloodstream Infections Among Solid Organ Transplant Recipients
    Anesi, J. A.
    Lautenbach, E.
    Tamma, P. D.
    Thom, K. A.
    Alby, K.
    Blumberg, E. A.
    Bilker, W.
    Omorogbe, J.
    Tolomeo, P.
    Werzen, A.
    Han, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 407 - 408
  • [38] Candida bloodstream infections in hemodialysis recipients
    Pyrgos, Vasilios
    Ratanavanich, Kathryn
    Donegan, Nancy
    Veis, Judith
    Walsh, Thomas J.
    Shoham, Shmuel
    [J]. MEDICAL MYCOLOGY, 2009, 47 (05) : 463 - 467
  • [39] Updates in Prevention, Diagnosis, and Management of Infections Among Solid Organ Transplant Recipients
    Imlay, Hannah
    Hanson, Kimberly E.
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2023, 37 (03) : 13 - 15
  • [40] Human herpesvirus type 8 infections among solid organ transplant recipients
    Allen, UD
    [J]. PEDIATRIC TRANSPLANTATION, 2002, 6 (03) : 187 - 192